Actavis to Present at 33rd Annual J.P. Morgan Healthcare Conference

Dec 22, 2014, 09:00 ET from Actavis plc

DUBLIN, Dec. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that Brent Saunders, CEO and President of Actavis, will provide an overview and update of the Company's business at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO

The presentation will take place on Tuesday, January 13, 2015 at 10:30 AM Pacific Standard Time at the Westin St. Francis, 335 Powell St, San Francisco, CA 94102. To access a live webcast of the presentation, visit Actavis' Investor Relations Web site at http://ir.actavis.com.  The webcast can also be accessed at the following URL:

http://jpmorgan.metameetings.com/confbook/healthcare15/directlink?p=16881

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Actavis

Actavis plc (NYSE: ACT), headquartered in Dublin, Ireland, is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world. 

Actavis markets a broad portfolio of branded and generic pharmaceuticals and develops innovative medicines for patients suffering from diseases principally in the central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory and anti-infective therapeutic categories. The company is an industry leader in product research and development, with one of the broadest brand development pipelines in the pharmaceutical industry, and a leading position in the submission of generic product applications. Actavis has commercial operations in more than 60 countries and operates more than 30 manufacturing and distribution facilities around the world.

For more information, visit Actavis' website at www.actavis.com.

CONTACTS:

Investors:


Lisa DeFrancesco


(862) 261-7152




Media:


Charlie Mayr


(862) 261-8030




David Belian


(862) 261-8141

SOURCE Actavis plc



RELATED LINKS

http://www.actavis.com